論文・総説 - 末永　光邦

分割表示  324 件中 81 - 100 件目  ／  全件表示 >>

  1. Nakayama Izuma, Chin Keisho, Matsushima Tomohiro, Takahari Daisuke, Ogura Mariko, Shinozaki Eiji, Suenaga Mitsukuni, Ozaka Masato, Wakatsuki Takeru, Ichimura Takashi, Hiroki Osumi, Yamaguchi Kensei. Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2017.12; 22 (6): 1060-1068. ( PubMed, DOI )

  2. Berger M. D., Stintzing S., Heinemann V., Yang D., Cao S., Sunakawa Y., Ning Y., Matsusaka S., Okazaki S., Miyamoto Y., Suenaga M., Schirripa M., Soni S., Zhang W., Falcone A., Loupakis F., Lenz H-J. Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials ANNALS OF ONCOLOGY. 2017.11; 28 (11): 2780-2785. ( DOI )

  3. Suenaga Mitsukuni, Schirripa Marta, Cao Shu, Zhang Wu, Yang Dongyun, Dadduzio Vincenzo, Salvatore Lisa, Borelli Beatrice, Pietrantonio Filippo, Ning Yan, Okazaki Satoshi, Berger Martin D., Miyamoto Yuji, Gopez Roel Jr., Barzi Afsaneh, Yamaguchi Toshiharu, Loupakis Fotios, Lenz Heinz-Josef. Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer EUROPEAN JOURNAL OF CANCER. 2017.11; 86 197-206. ( PubMed, DOI )

  4. Okazaki S, Schirripa M, Loupakis F, Cao S, Zhang W, Yang D, Ning Y, Berger MD, Miyamoto Y, Suenaga M, Iqubal S, Barzi A, Cremolini C, Falcone A, Battaglin F, Salvatore L, Borelli B, Helentjaris TG, Lenz HJ. Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Cancer. 2017.11; 123 (22): 4506-4514. ( PubMed, DOI )

  5. Okazaki Satoshi, Stintzing Sebastian, Sunakawa Yu, Cao Shu, Zhang Wu, Yang Dongyun, Ning Yan, Matsusaka Satoshi, Berger Martin D., Miyamoto Yuji, Suenaga Mitsukuni, Schirripa Marta, West Jordan D., Gopez Roel, Akihito Tsuji, Ichikawa Wataru, Heinemann Volker, DePaolo R. William, Lenz Heinz-Josef. Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer INTERNATIONAL JOURNAL OF CANCER. 2017.09; 141 (6): 1222-1230. ( PubMed, DOI )

  6. Schirripa Marta, Zhang Wu, Heinemann Volker, Cao Shu, Okazaki Satoshi, Yang Dongyun, Loupakis Fotios, Berger Martin D., Ning Yan, Miyamoto Yuji, Suenaga Mitsukuni, Gopez Roel F., West Jordan D., Hanna Diana, Barzi Afsaneh, Falcone Alfredo, Stintzing Sebastian, Lenz Heinz-Josef. Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial INTERNATIONAL JOURNAL OF CANCER. 2017.07; 141 (2): 383-392. ( PubMed, DOI )

  7. Miyamoto Yuji, Stintzing Sebastian, Heinemann Volker, Zhang Wu, Cao Shu, Okazaki Satoshi, Berger Martin D., Suenaga Mitsukuni, Schirripa Marta, Soni Shivani, Matsusaka Satoshi, Ning Yan, Yang Dongyun, Gopez Roel, Melendez Elizabeth, Hanna Diana L., Barzi Afsaneh, Baba Hideo, Lenz Heinz-Josef. Association of genetic variations in genes implicated in the axis with outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with cetuximab plus chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2017.05; 35 ( DOI )

  8. Osumi Hiroki, Shinozaki Eiji, Suenaga Mitsukuni, Wakatsuki Takeru, Nakayama Izuma, Matsushima Tomohiro, Ogura Mariko, Ichimura Takashi, Takahari Daisuke, Chin Keisho, Nagasaki Toshiya, Konishi Tsuyoshi, Akiyoshi Takashi, Fujimoto Yoshiya, Nagayama Satoshi, Fukunaga Yosuke, Ueno Masashi, Yamaguchi Kensei. Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer PLOS ONE. 2017.05; 12 (5): e0176745. ( PubMed, DOI )

  9. Berger Martin D., Yamauchi Shinichi, Cao Shu, Hanna Diana L., Sunakawa Yu, Schirripa Marta, Matsusaka Satoshi, Yang Dongyun, Groshen Susan, Zhang Wu, Ning Yan, Okazaki Satoshi, Miyamoto Yuji, Suenaga Mitsukuni, Lonardi Sara, Cremolini Chiara, Falcone Alfredo, Heinemann Volker, Loupakis Fotios, Stintzing Sebastian, Lenz Heinz-Josef. Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials EUROPEAN JOURNAL OF CANCER. 2017.05; 77 13-20. ( PubMed, DOI )

  10. Suenaga Mitsukuni, Cao Shu, Stintzing Sebastian, Zhang Wu, Yang Dongyun, Ning Yan, Okazaki Satoshi, Berger Martin D., Miyamoto Yuji, Schirripa Marta, Gopez Roel, Melendez Elizabeth, Soni Shivani, Barzi Afsaneh, Yamaguchi Toshiharu, Heinemann Volker, Lenz Heinz-Josef. Genetic polymorphisms of CCL5 and CCR5 to predict efficacy of cetuximab-based treatment in metastatic colorectal cancer patients depending on primary tumor location. JOURNAL OF CLINICAL ONCOLOGY. 2017.05; 35 ( DOI )

  11. Berger Martin D., Stintzing Sebastian, Yang Dongyun, Cao Shu, Miyamoto Yuji, Suenaga Mitsukuni, Soni Shivani, Gopez Roel, Melendez Elizabeth, Zhang Wu, Heinemann Volker, Lenz Heinz-Josef. Genetic variations within the vitamin C transporter genes to predict outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizurnab Data from FIRE-3 trial. JOURNAL OF CLINICAL ONCOLOGY. 2017.05; 35 ( DOI )

  12. Miyamoto Yuji, Loupakis Fotios, Zhang Wu, Cao Shu, Okazaki Satoshi, Berger Martin D., Suenaga Mitsukuni, Schirripa Marta, Soni Shivani, Matsusaka Satoshi, Ning Yan, Yang Dongyun, Gopez Roel, Melendez Elizabeth, Hanna Diana L., Barzi Afsaneh, Baba Hideo, Falcone Alfredo, Lenz Heinz-Josef. Genetic variations in semaphorin/neuropilin signaling to predict clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) receiving bevacizumab-based chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2017.05; 35 ( DOI )

  13. Suenaga M., Schirripa M., Cao S., Zhang W., Yang D., Murgioni S., Rossini D., Marmorino F., Mennitto A., Ning Y., Okazaki S., Berger M. D., Miyamoto Y., Gopez R. Jr., Barzi A., Yamaguchi T., Loupakis F., Lenz H. -J.. Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer ANNALS OF ONCOLOGY. 2017.05; 28 (5): 1015-1022. ( DOI )

  14. Suenaga Mitsukuni, Cao Shu, Zhang Wu, Ning Yan, Okazaki Satoshi, Berger Martin D., Miyamoto Yuji, Schirripa Marta, Gopez Roel, Melendez Elizabeth, Soni Shivani, Barzi Afsaneh, Yamaguchi Toshiharu, Lenz Heinz-Josef. Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels to predict efficacy of bevacizumab in metastatic colorectal cancer patients receiving first-line chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2017.05; 35 ( DOI )

  15. Fukuda Naoki, Takahari Daisuke, Osumi Hiroki, Matsushima Tomohiro, Nakayama Izuma, Wakatsuki Takeru, Ogura Mariko, Ichimura Takashi, Ozaka Masato, Suenaga Mitsukuni, Shinozaki Eiji, Chin Keisho, Yamaguchi Kensei. Analysis of predictive factors of ramucirumab plus paclitaxel for advanced gastric cancer. JOURNAL OF CLINICAL ONCOLOGY. 2017.02; 35 (4):

  16. Osumi Hiroki, Takahari Daisuke, Shinozaki Eiji, Chin Keisho, Ogura Mariko, Nakayama Izuma, Matsushima Tomohiro, Wakatsuki Takeru, Ichimura Takashi, Suenaga Mitsukuni, Yamaguchi Kensei. Comparison of early tumor shrinkage between oxaliplatin plus S-1 and cisplatin plus S-1 in first-line chemotherapy with advanced gastric cancer. JOURNAL OF CLINICAL ONCOLOGY. 2017.02; 35 (4):

  17. Yagi Shusuke, Wakatsuki Takeru, Yamamoto Noriko, Chin Keisho, Takahari Daisuke, Ogura Mariko, Ichimura Takashi, Nakayama Izuma, Matsushima Tomohiro, Osumi Hiroki, Suenaga Mitsukuni, Ozaka Masato, Shinozaki Eiji, Ishikawa Yuichi, Yamaguchi Kensei. Clinical significance of intratumoral HER2 heterogeneity (IHH) using endoscopic biopsy specimens in patients with HER2-positive gastric cancer (GC) who received T-mab-based chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2017.02; 35 (4):

  18. Wakatsuki Takeru, Shinozaki Eiji, Suenaga Mitsukuni, Nakayama Izuma, Matsushima Tomohiro, Osumi Hiroki, Ichimura Takashi, Ogura Mariko, Takahari Daisuke, Ozaka Masato, Chin Keisho, Yamaguchi Kensei. Associations between regorafenib-induced adverse events (AEs) and efficacy in metastatic colorectal cancer (mCRC). JOURNAL OF CLINICAL ONCOLOGY. 2017.02; 35 (4):

  19. Berger Martin D., Stintzing Sebastian, Heinemann Volker, Yang Dongyun, Cao Shu, Ning Yan, Okazaki Satoshi, Miyamoto Yuji, Suenaga Mitsukuni, Schirripa Marta, Gopez Roel, Hanna Diana L., Zhang Wu, Lenz Heinz-Josef. Effect of JAK2 SNP rs2274472 on outcome for mCRC patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 trial. JOURNAL OF CLINICAL ONCOLOGY. 2017.02; 35 (4):

  20. Suenaga Mitsukuni, Schirripa Marta, Cao Shu, Zhang Wu, Yang Dongyun, Salvatore Lisa, Lonardi Sara, Moretto Roberto, Borelli Beatrice, Ning Yan, Okazaki Satoshi, Berger Martin D., Miyamoto Yuji, Gopez Roel, Hanna Diana L., Barzi Afsaneh, Wakatsuki Takeru, Yamaguchi Toshiharu, Loupakis Fotios, Lenz Heinz-Josef. Genetic variants of genes in CCL5/CCR5 pathway to predict regorafenib-induced hand-foot skin reaction in patients with refractory metastatic colorectal cancer: A report of ethnic difference. JOURNAL OF CLINICAL ONCOLOGY. 2017.02; 35 (4):

< 前のページ - 次のページ >

このページの先頭へ▲